Maria Kristina Wigenfeldt
Comptroller/Controller/Auditor presso Quantovir AB
Posizioni attive di Maria Kristina Wigenfeldt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Quantovir AB
 Quantovir AB Miscellaneous Commercial ServicesCommercial Services Quantovir AB conducts research and development of methods for cancer diagnostics and related business. It develops technology for quantitative measurement of high-risk Human Papillomavirus (HPV) types using deoxyribonucleic acid (DNA)-based detection. It demonstrates that a molecular diagnostic test measuring the quantity, or viral load, of HPV DNA present in cervical specimens can be used to predict a woman's risk of developing cervical cancer. The company was founded by Ulf Gyllensten on February 28, 2001 and is headquartered in Uppsala, Sweden. | Comptroller/Controller/Auditor | - | - |
Storia della carriera di Maria Kristina Wigenfeldt
Statistiche
Distribuzione geografica
| Svezia | 2 |
Posizioni
| Comptroller/Controller/Auditor | 1 |
Settori
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Quantovir AB
Quantovir AB Miscellaneous Commercial ServicesCommercial Services Quantovir AB conducts research and development of methods for cancer diagnostics and related business. It develops technology for quantitative measurement of high-risk Human Papillomavirus (HPV) types using deoxyribonucleic acid (DNA)-based detection. It demonstrates that a molecular diagnostic test measuring the quantity, or viral load, of HPV DNA present in cervical specimens can be used to predict a woman's risk of developing cervical cancer. The company was founded by Ulf Gyllensten on February 28, 2001 and is headquartered in Uppsala, Sweden. | Commercial Services |
